Juan Yan

803 total citations
24 papers, 565 citations indexed

About

Juan Yan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Juan Yan has authored 24 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Juan Yan's work include Cell death mechanisms and regulation (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Peptidase Inhibition and Analysis (2 papers). Juan Yan is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Peptidase Inhibition and Analysis (2 papers). Juan Yan collaborates with scholars based in China and United States. Juan Yan's co-authors include Xun Huang, Jian Ding, Meiyu Geng, Xuhong Fu, Minjia Tan, Min Huang, Qingbing Meng, Xingling Zheng, Hong Yang and Yi Su and has published in prestigious journals such as Cell, Analytical Biochemistry and Clinical Cancer Research.

In The Last Decade

Juan Yan

24 papers receiving 554 citations

Peers

Juan Yan

IMMUN

ONCOL

PRM

Fugen Shangguan China

Begoña Cánovas Spain

Shudong Zhu China

Cristina Andreani Italy

Weiwei Shao China

Ae Jin Jeong South Korea

Danfeng Xue China

Jingyu Zhang China

Yingze Wei China

Mabel T. Padilla United States

Fugen Shangguan China

Juan Yan

333 ×0.9

126 ×1.0

65 ×0.8

IMMUN

62 ×0.8

ONCOL

60 ×1.3

PRM

Citations per year, relative to Juan Yan Juan Yan (= 1×) peers Fugen Shangguan

Countries citing papers authored by Juan Yan

Since Specialization

Citations

This map shows the geographic impact of Juan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Yan more than expected).

Fields of papers citing papers by Juan Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Yan. The network helps show where Juan Yan may publish in the future.

Co-authorship network of co-authors of Juan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Yan. A scholar is included among the top collaborators of Juan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Yan. Juan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ran, Leili, Amish J. Patel, Juan Yan, et al.. (2024). MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. Clinical Cancer Research. 30(22). 5154–5165. 2 indexed citations

Xia, Wei, C. N. Luo, Li Cai, et al.. (2024). Environmental impact study of the sightseeing electric vehicle supply chain based on the B2C e-commerce model and LCA framework. Energy Informatics. 7(1). 1 indexed citations

Ma, Liping, Jie Chen, Mengmeng Liu, et al.. (2023). Biodosimetry Based on Gamma-H2AX Quantification in Human Peripheral Blood Lymphocytes after Partial-body Irradiation. Health Physics. 126(3). 134–140. 1 indexed citations

Chen, Yingtai, Jianhua Yin, Lulu Zhao, et al.. (2022). Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. Journal of Translational Medicine. 20(1). 563–563. 14 indexed citations

Xu, Yanying, et al.. (2021). Method development and validation of sildenafil, N-desmethylsildenafil and N1,N4-desmethylsildenafil by LC-MS/MS and its application. Analytical Biochemistry. 631. 114355–114355. 5 indexed citations

Yan, Juan, et al.. (2021). C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways. Journal of Cancer. 12(14). 4341–4354. 12 indexed citations

Huang, Min, et al.. (2021). Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway. Oncology Letters. 21(6). 438–438. 3 indexed citations

Yan, Juan, Xiaomin Li, Yanxin Zhang, et al.. (2020). Bioequivalence and Evaluation Parameters Based on the Pharmacodynamics of Miglitol in Healthy Volunteers. Clinical Pharmacology in Drug Development. 10(6). 582–587. 2 indexed citations

Zhang, Xiaoqing, et al.. (2019). Vitexin protects against ischemia/reperfusion-induced brain endothelial permeability. European Journal of Pharmacology. 853. 210–219. 22 indexed citations

10.

Huang, Min, Hong Zhu, Yi Cheng, et al.. (2018). A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer. Cancer Chemotherapy and Pharmacology. 82(5). 829–838. 10 indexed citations

11.

Yan, Juan, et al.. (2018). Toosendanin mediates cisplatin sensitization through targeting Annexin A4/ATP7A in non-small cell lung cancer cells. Journal of Natural Medicines. 72(3). 724–733. 21 indexed citations

12.

Huang, Xun, Juan Yan, Min Zhang, et al.. (2018). Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors. Cell. 175(1). 186–199.e19. 204 indexed citations

13.

Dai, Xiaoyang, Juan Yan, Xuhong Fu, et al.. (2017). Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase. Clinical Cancer Research. 23(20). 6267–6278. 98 indexed citations

14.

Zhu, Hong, et al.. (2017). TRAIL mutant membrane penetrating peptide alike (TMPPA) TRAIL-Mu3 enhances the antitumor effects of TRAIL in vitro and in vivo. Molecular Medicine Reports. 16(6). 9607–9612. 4 indexed citations

15.

Wang, Xiuyun, Min Huang, Chen Chen, et al.. (2017). Generation of a novel TRAIL mutant by proline to arginine substitution based on codon bias and its antitumor effects. Molecular Medicine Reports. 16(4). 4973–4979. 2 indexed citations

16.

Yan, Juan, et al.. (2013). Chrysophanol Liposome Preconditioning Protects against Cerebral Ischemia-reperfusion Injury by Inhibiting Oxidative Stress and Apoptosis in Mice. International Journal of Pharmacology. 10(1). 55–68. 11 indexed citations

17.

Meng, Qingbing, et al.. (2012). TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Molecular and Cellular Biochemistry. 371(1-2). 177–186. 63 indexed citations

18.

Meng, Qingbing, Hongbing Liu, Wensheng Zhang, et al.. (2012). SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Molecular and Cellular Biochemistry. 373(1-2). 201–210. 41 indexed citations

19.

Chen, Yao, Dongsheng Ouyang, Guoping Yang, et al.. (2011). Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers. Xenobiotica. 42(6). 596–602. 11 indexed citations

20.

Yan, Juan, et al.. (2006). Induction of G1 arrest and differentiation in MDA-MB-231 breast cancer cell by boehmeriasin A, a novel compound from plant. International Journal of Gynecological Cancer. 16(1). 165–170. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact